Du Cheng
Papers
1
Total Citations
2
H-Index
1
About
Du Cheng is a leading voice at the intersection of nanomedicine and gene editing, with a primary focus on developing advanced nanotheranostic platforms for liver diseases. His most notable contribution is the pioneering work on CRISPR/Cas-based nanotheranostics for viral hepatitis and hepatocellular carcinoma, a breakthrough that conceptualizes nanoscale CRISPR systems as "smart enzymatic robots" capable of precise therapeutic and diagnostic functions. This innovative approach, highlighted in his highly cited *Advanced Science* article (2021), demonstrates how nanotechnology can overcome traditional delivery barriers for CRISPR components, offering a dual strategy for both detecting and treating liver malignancies. By engineering these multifunctional nanoparticles, Du Cheng has opened new avenues for tackling two of the most challenging liver pathologies. His work, which has garnered significant attention in the biomedical community, represents a critical step toward translating CRISPR technology from bench to bedside, particularly for diseases that have long eluded effective treatment. Through these contributions, Du Cheng is helping to shape the future of precision nanomedicine in oncology and hepatology.
Research Focus
Key Achievements
Top Papers
- 1